#61 Addressing COVID Vaccine hesitancy
With Prof Annelies Wilder-Smith
Further resources:
- Christians and the Vaccine
- The Lancet article - Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel (May 5, 2021)
- The role & impact of faith actors in overcoming barriers to COVID-19 vaccination - A webinar from WHO, UNICEF & Religions for Peace (June 17, 2021)
Prof Annelies Wilder-Smith
Dr. Annelies Wilder-Smith has devoted her career to emerging infectious diseases, particularly those impacting low- and middle-income countries. Her path was shaped during two decades in Asia, where she was at the forefront of the SARS outbreak, and investigated the H5N1, dengue and Zika virus outbreaks. During the COVID-19 pandemic, she served as an external advisor to the World Health Organization, where she developed COVID-19 vaccine policies for the global use.
Annelies is Honorary Professor of Emerging Infectious Diseases at the London School of Hygiene and Tropical Medicine, Past President of the International Society of Travel Medicine, and Editor-in-Chief of the Journal of Travel Medicine. Her academic career resulted in 380 publications and many research grants. She leads the Lancet Commission on Dengue and was Principal Investigator of EU-funded research consortia.
Her awards include the Myron Levine Vaccinology Prize and the CDC Honor Group Award. Annelies is also the author of Travel Medicine: Tales Behind the Science and Grasping Heaven, a biography of Dr. Tami Fisk. She lives in Switzerland with her husband, a professor of neurology; both their children are physicians in training.
